The Motley Fool

Here’s how this stock turned £1,000 into £19,000

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Judges Scientific (LSE: JDG) is the sort of success story investors dream about. The share price is up 1,900% in the last 10 years and in my opinion, it’s all down to the wonderful strategy executed by CEO David Cicurel and Chairman Alex Hambro. Note that I’ve not included dividends in that return figure, of which there have been plenty.

The two founders have followed a simple yet powerful strategy. The company acquires niche leaders in scientific testing and measuring equipment at reasonable prices, before growing them under the decentralised Judges Scientific umbrella. Usually, it pays down any debt on the balance sheet to allow unencumbered growth, while also supplying the capital necessary for its businesses to maintain their market-leading positions. 

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Cicurel has an uncanny knack of acquiring these businesses at dirt-cheap prices too and by my estimation is still finding great deals even in today’s bull market. 

The shares haven’t exactly had the best time of it in recent years, however. The demand for scientific testing equipment isn’t constant, resulting in some choppy results. 

On top of that, the shares are down 10% today at the time of writing after the company announced that Cicurel has sold 157,727 shares. That’s 2.58% of all outstanding shares. 

However, the fall seems overdone to me and I view this as a buying opportunity. After all, even after that sale, the CEO still owns 12.4% of the company. Investors are worrying that the top executive is selling ahead of bad news but I feel we owe him a little more faith, given his wonderful track record. 

40+ years of dividend hikes

What sort of a business can increase its dividend for more than 40 consecutive years? I’d expect many investors to suggest a utility, a pharmaceutical company or perhaps some other non-cyclical stock. I don’t think many would guess that James Halstead (LSE: JHD), a manufacturer of specialist flooring, would have managed it, but it’s true. 

It’s an impressive result for a company that essentially sells a commodity. When I spoke to the management team a year or so ago, it seemed clear that a tireless focus on cost control and quality of product had propelled the business for decades. 

Perhaps this culture was borne out of its family-run roots (the clue’s in the name). The company has, after all, boasted a net cash position every year since 1997. Last year, revenue grew 6.5%, with earnings per share rising 3.5%. The final dividend was hiked a greater 8.8% but still remained generously covered by earnings. 

Perhaps the most impressive aspect of the business is its profitability. It achieved a 19.6% operating margin last year. 

I keep a close eye on Halstead, but trading at a P/E of 25 I get the feeling investors could wait for a better entry point. In my view, the 10% fall in Judges makes it the better buy, although the track record of both these companies is to be admired.

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic…

And with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be daunting prospect during such unprecedented times.

Fortunately, The Motley Fool is here to help: our UK Chief Investment Officer and his analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global lock-down…

You see, here at The Motley Fool we don’t believe “over-trading” is the right path to financial freedom in retirement; instead, we advocate buying and holding (for AT LEAST three to five years) 15 or more quality companies, with shareholder-focused management teams at the helm.

That’s why we’re sharing the names of all five of these companies in a special investing report that you can download today for FREE. If you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio, and that you can consider building a position in all five right away.

Click here to claim your free copy of this special investing report now!

Zach Coffell owns shares in Judges Scientific. The Motley Fool UK has recommended Judges Scientific. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply click below to discover how you can take advantage of this.